OTCM
HVRRF
Market cap37bUSD
Oct 09, Last price
295.00
Name
Hannover Rueck SE
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hannover Rück SE, along with its group entities, offers a broad spectrum of reinsurance products and services worldwide. Operations are structured around two principal segments: Property & Casualty Reinsurance, and Life & Health Reinsurance. Within Property & Casualty Reinsurance, its offerings span traditional property and casualty coverage, facultative arrangements, extensive catastrophe excess-of-loss protection, custom-tailored structured reinsurance, and innovative insurance-linked securities. The company further specializes in risk solutions for agriculture, livestock, bloodstock, aviation, space, marine, and offshore energy industries, in addition to providing coverage for credit, surety, and political risks. Its Life & Health Reinsurance segment encompasses a range of products including group and individual credit life, enhanced annuities, collective life and health schemes, and Takaful reinsurance. It also engineers risk solutions addressing critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm delivers diverse financial solutions, such as financing new business ventures, monetizing embedded value, providing reserve and solvency relief, and assisting with the divestiture of non-core operations. Founded in 1966, the company maintains its headquarters in Hanover, Germany. It was formerly known as Hannover Rückversicherung AG before rebranding to Hannover Rück SE in March 2013. Hannover Rück SE functions as a subsidiary of Talanx AG.
Related entities
Parent (2)
HDI Haftpflichtverband der Deutschen Industrie Versicherungsverein auf Gegenseitigkeit
Subsidiaries (30)
cor F 25. GmbH & Co. KG
DYNASTIC UNDERWRITING LIMITED
E+S Ruckversicherung AG
FUNIS GmbH & Co. KG
Glencar Insurance Corporation
HANNOVER AFRICA
Hannover Finance (Luxembourg) S.A.
HANNOVER FINANCE INC.
Hannover Insurance-Linked Securities GmbH & Co. KG
HANNOVER LIFE RE OF AUSTRALASIA LTD
HANNOVER LIFE REASSURANCE COMPANY OF AMERICA
Hannover Life Reassurance Company of America (Bermuda) Ltd.
Hannover Re (Bermuda) Ltd.
HANNOVER RE (IRELAND) DESIGNATED ACTIVITY COMPANY
Hannover Re Euro PE Holdings GmbH & Co. KG
Hannover Re Euro RE Holdings GmbH
Hannover Re Global Alternatives GmbH & Co. KG
HANNOVER RE SOUTH AFRICA
Hannover Reinsurance Group Africa Proprietary Limited
HANNOVER RETAKAFUL B.S.C. (CLOSED)
Key people
Clemens Jungsthofel
Chairman of the Executive Board · since 2025
Sven Althoff
Member of the Executive Board · since 2014
Claude Chevre
Member of the Executive Board · since 2011
Jean-Jacques Henchoz
Chief Executive Officer, Member of the Executive Board · since 2025
Christian Hermelingmeier
Chief Financial Officer, Member of the Executive Board · since 2025
Brona Magee
Member of the Executive Board · since 2025
Sharon Ooi
Member of the Executive Board · since 2023
Silke Sehm
Member of the Executive Board · since 2019
Thorsten Steinmann
Member of the Executive Board · since 2024
Independent Chairman of the Supervisory Board · since 2019
Ursula Lipowsky
Independent Member of the Supervisory Board · since 2018
Michael Ollmann
Independent Member of the Supervisory Board · since 2019
Andrea Pollak
Independent Member of the Supervisory Board · since 2011
Member of the Supervisory Board, Employee representative · since 2019
Deputy Chairman of the Supervisory Board · since 2019
Frauke Heitmueller
Member of the Supervisory Board, Employee Representative · since 2012
Iika Hundeshagen
Member of the Supervisory Board, Employee Representative · since 2019
Timo Kaufmann
Member of the Supervisory Board, Employee Representative · since 2024
Harald Kayser
Member of the Supervisory Board · since 2024
Sibylle Kempff
Member of the Supervisory Board, Employee Representative · since 2024
Headquarters & legal address
Karl-Wiechert-Allee 50
Hannover, NI 30625
DE
Hannover, NI 30625
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||